DOI QR코드

DOI QR Code

Induced Death of Escherichia coli Encapsulated in a Hollow Fiber Membrane as Observed In Vitro or After Subcutaneous Implantation

  • Granicka, L. H. (Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science) ;
  • Zolnierowicz, J. (Medical Center of Postgraduate Education) ;
  • Wasilewska, D. (Medical Center of Postgraduate Education) ;
  • Werynski, A. (Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science) ;
  • Kawiak, J. (Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science)
  • 발행 : 2010.01.31

초록

The encapsulation of bacteria may be used to harness them for longer periods of time in order to make them viable, whereas antibiotic treatment would result in controlled release of therapeutic molecules. Encapsulated Escherichia coli GFP (green fluorescent protein) (E. coli GFP) was used here as a model for therapeutic substance - GFP fragments release (model of bioactive substances). Our aim was to evaluate the performance of bacteria encapsulated in hollow fibers (HFs) treated with antibiotic for induction of cell death. The polypropylene-surface-modified HFs were applied for E. coli encapsulation. The encapsulated bacteria were treated with tetracycline in vitro or in vivo during subcutaneous implantation into mice. The HF content was evaluated in a flow cytometer, to assess the bacteria cell membrane permeability changes induced by tetracycline treatment. It was observed that the applied membranes prevented release of bacteria through the HF wall. The E. coli GFP culture encapsulated in HF in vitro proved the tetracycline impact on bacteria viability and allows the recognition of the sequence of events within the process of bacteria death. Treatment of the SCID mice with tetracycline for 8 h proved the tetracycline impact on bacteria viability in vivo, raising the necrotic bacteria-releasing GFP fragments. It was concluded that the bacteria may be safely enclosed within the HF at the site of implantation, and when the animal is treated with antibiotic, bacteria may act as a local source of fragments of proteins expressed in the bacteria, a hypothetical bioactive factor for the host eukaryotic organism.

키워드

참고문헌

  1. Chandramouli, V., K. Kailasapathy, P. Peiris, and M. Jones. 2004. An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J. Microbiol. Methods 56: 27-35. https://doi.org/10.1016/j.mimet.2003.09.002
  2. Ding, W. K. and N. P. Shah. 2009. An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage. J. Food Sci. 74: M53-M61. https://doi.org/10.1111/j.1750-3841.2008.01030.x
  3. Granicka, L. H., M. Wdowiak, A. Kosek, S. Swiezewski, D. Wasilewska, E. Jankowska, A. Werynski, and J. Kawiak. 2005. Survival analysis of Escherichia coli encapsulated in hollow fibre membrane in vitro & in vivo. Preliminary report. Cell Transplant 14: 323-330. https://doi.org/10.3727/000000005783983043
  4. Hoskins, J. R., K. Yanagihara, K. Mizuuchi, and S. Wickner. 2002. ClpAP and ClpXP degrade proteins with tags located in the interior of the primary sequence. Proc. Natl. Acad. Sci. U.S.A. 99: 11037-11042. https://doi.org/10.1073/pnas.172378899
  5. Kumar, T. D., K. Balakrishna, H. S. Murali, and H. V. Batra. 2009. Construction of a recombinant intergenus multidomain chimeric protein for simultaneous expression of haemolysin BL of Bacillus cereus, listeriolysin O of Listeria monocytogenes and enterotoxin B of Staphylococcus aureus. J. Med. Microbiol. 58: 577-583. https://doi.org/10.1099/jmm.0.007658-0
  6. Maglica, Z., F. Striebel, and E. Weber-Ban. 2008. An intrinsic degradation tag on the ClpA C-terminus regulates the balance of ClpAP complexes with different substrate specificity. J. Mol. Biol. 384: 503-511. https://doi.org/10.1016/j.jmb.2008.09.046
  7. Moslemy, P., R. J. Neufeld, and S. R. Guiot. 2002. Biodegradation of gasoil by gellan gum-encapsulated bacterial cells. Biotech. Bioeng. 80: 175-184. https://doi.org/10.1002/bit.10358
  8. Prakash, S. and T. M. Chang. 2000. Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in vitro and in vivo. Artif. Cell Blood Substit. Immobil. Biotechnol. 28: 397-408. https://doi.org/10.3109/10731190009118584
  9. Prakash, S. and T. M. Chang. 2000. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells. Int. J. Artif. Organs 23: 429-435.
  10. Sultana, K., G. Godward, N. Reynolds, R. Arumugaswamy, P. Peiris, and K. Kailasapathy. 2000. Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. Int. J. Food Microbiol. 62: 47-55. https://doi.org/10.1016/S0168-1605(00)00380-9
  11. Vera, A., A. Aris, M. Carrio, N. Gonzalez-Montalban, and A. Villaverde. 2005. Lon and ClpP proteases participate in the physiological disintegration of bacterial inclusion bodies. J. Biotechnol. 119: 163-171. https://doi.org/10.1016/j.jbiotec.2005.04.006

피인용 문헌

  1. Cytotoxicity of Listeriolysin O Produced by Membrane-Encapsulated Bacillus subtilis on Leukemia Cells vol.21, pp.11, 2010, https://doi.org/10.4014/jmb.1105.05040